Quick Answer
MEDICINOVA INC reported Net Income Loss of -$12.00 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -8.6% in Net Income Loss from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2005 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 21 years of available data (2005 to 2025), MEDICINOVA INC's Net Income Loss has grown by 53.3%.
- Historical annual values: Fiscal year 2025: -$12.00 million | Fiscal year 2024: -$11.05 million | Fiscal year 2023: -$8.57 million | Fiscal year 2022: -$14.07 million | Fiscal year 2021: -$10.13 million | Fiscal year 2020: -$13.85 million | Fiscal year 2019: -$12.94 million | Fiscal year 2018: -$14.68 million | Fiscal year 2017: -$11.16 million | Fiscal year 2016: -$10.87 million | Fiscal year 2015: -$8.85 million | Fiscal year 2014: -$9.20 million | Fiscal year 2013: -$4.03 million | Fiscal year 2012: -$10.96 million | Fiscal year 2011: -$17.73 million | Fiscal year 2010: -$20.19 million | Fiscal year 2009: -$20.37 million | Fiscal year 2008: -$21.92 million | Fiscal year 2007: -$48.90 million | Fiscal year 2006: -$35.69 million | Fiscal year 2005: -$25.69 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: